Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Enzo Biochem Inc. (ENZ)

3.23   -0.01 (-0.31%) 05-24 16:02
Open: 3.25 Pre. Close: 3.24
High: 3.29 Low: 3.19
Volume: 55,915 Market Cap: 153M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.311 - 3.343 3.343 - 3.362
Low: 3.123 - 3.164 3.164 - 3.189
Close: 3.182 - 3.25 3.25 - 3.291

Technical analysis

as of: 2019-05-24 4:26:16 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 4.14     One year: 4.40
Support: Support1: 3.17    Support2: 2.64
Resistance: Resistance1: 3.54    Resistance2: 3.77
Pivot: 3.54
Moving Average: MA(5): 3.34     MA(20): 3.54
MA(100): 3.34     MA(250): 3.88
MACD: MACD(12,26): -0.01     Signal(9): 0.05
Stochastic oscillator: %K(14,3): 10.37     %D(3): 14.48
RSI: RSI(14): 35.59
52-week: High: 6.76  Low: 2.32  Change(%): -50.8
Average Vol(K): 3-Month: 21454  10-Days: 20229

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ENZ has closed above bottom band by 3.8%. Bollinger Bands are 11.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 22 Apr 2019 20:29:19 Z
Health Care Sector Update for 04/22/2019: ENZ,HOLX,GRFS,TNXP,MBRX,ISRG

Mon, 22 Oct 2018 14:08:34 Z
Enzo Biochem Trades At A Discount To Its Sum Of The Parts Value With Multiple Ways To Win

Tue, 12 Jun 2018 21:11:26 Z
Mid-Afternoon Market Update: Enzo Biochem Falls After Q3 Results; Galmed Pharmaceuticals Shares Surge

Tue, 12 Jun 2018 17:06:53 Z
Mid-Morning Market Update: Markets Mostly Higher; Lands' End Posts Upbeat Q1 Results

Tue, 24 Apr 2018 20:27:12 Z
Health Care Sector Update for 04/24/2018: ENZ,HOLX,BIIB,CNC,INCY

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M) 47.24
Shares Float (M) 41.56
% Held by Insiders
% Held by Institutions 83.90
Shares Short (K) 1312
Shares Short P. Month (K)

Stock Financials

EPS Est. Current Year -0.020
EPS Est. Next Year 0.040
EPS Est. Next Quarter -0.010
Forward EPS 0.020
Book Value (p.s.) 2.570
PEG Ratio
Profit Margin -31.02
Operating Margin -25.34
Return on Assets (ttm) -23.5
Return on Equity (ttm) -29.8
Qtrly Rev. Growth -26.1
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -18.41
Levered Free Cash Flow (M) -17.14

Stock Valuations

P/E Growth Ratio
P/BV 1.26
P/S 77849592.00
P/CF -8.29

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.